Celso Arango, MD, PhD: Clinical Trials

1 trial sponsored by Celso Arango, MD, PhD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Celso Arango, MD, PhD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Arbaclofen in Children and Adolescents With ASD
Arbaclofen, Placebo - Autism Spectrum Disorder
Phase 2CompletedCelso Arango, MD, PhD1242019-09-192023-02-08

Conditions studied

Autism Spectrum Disorder (1)  ·  Social Adjustment (1)

Interventions

Butyric Acid (1)  ·  arbaclofen placarbil (1)

Countries

France (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Andre Strydom, Prof. (1)  ·  Celso Arango, Prof. (1)  ·  Jeremy Parr, Prof. (1)  ·  Mallika Punukollu, Dr. (1)  ·  Mara Parellada, Prof. (1)  ·  Richard Delorme, Prof. (1)  ·  Rosa Calvo, Dr. (1)

Results publications

PMID 34504446, PMID 41631164

NIH funding

2018 (1)